Notice of meeting to the Ordinary and Extraordinary General Meeting dated May 25, 2023 The shareholders of INVENTIVA are informed that the Ordinary and Extraordinary General. | April 17, 2023
Daix , Long Island City , March 30, 2023 Inventiva , a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic. | March 30, 2023
Daix , Long Island City , March 23, 2023 - Inventiva , a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with. | March 23, 2023